Clinical Trial

pBFS Guided aiTBS Over Language Network for ASD Child

Recruiting
View on ClinicalTrials.gov →
Summary
The aim of this trial is to evaluate the efficacy and safety of precision neuromodulation in improving language ability in children with autism spectrum disorder (ASD) who also have language development delay. The neuromodulation will be delivered using the accelerated intermittent theta burst stimulation (aiTBS) protocol, targeting the language network in the left superior frontal gyrus (SFG), guided by personalized Brain Functional Sector (pBFS) technology.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-25.
Trial Details
NCT Number NCT06950437
Lead Sponsor Beijing Changping Tianhe Research Institute of Brain Science
Collaborators: Peking University Sixth Hospital, Shanghai Sunshine Rehabilitation Center
Conditions Autism Spectrum Disorder, Language Delay
Enrollment 150 participants
Start Date 2025-04-25
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-06-01 (estimated)
Updated on ClinicalTrials.gov 2025-05-11